We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App





Optical Chip on Disposable Card Could Detect COVID-19 Antibodies from Single Drop of Blood in One Minute

By LabMedica International staff writers
Posted on 19 Jan 2021
Researchers are developing an optical chip on a disposable card that can detect exposure to multiple viruses within a minute - including the coronavirus that causes COVID-19 - from a single drop of blood.

Led by the University of Rochester Medical Center (Rochester, NY, USA), the USD 1.7 million project is funded by the US Department of Defense Manufacturing Technology Program through a contract with AIM Photonics (Albany, NY, USA). More...
The collaboration also involves Ortho Clinical Diagnostics (Raritan, NJ, USA) which develops and manufactures innovative laboratory testing and blood-typing solutions.

The key to the technology is an optical chip, no larger than a grain of rice. Proteins associated with eight different viruses, including SARS-CoV-2, are contained in separate sensor areas of the chip. If someone has been exposed to any of the viruses, antibodies to those viruses in the blood sample will be drawn to the proteins and detected. The card will enable clinicians not only to detect and study COVID-19, but also to better understand potential relationships between COVID-19 infection and previous infections and immunity to other respiratory viruses, including circulating coronaviruses that cause the common cold. The researchers will now use blood drawn from 100 consenting convalescent COVID-19 patients to test the device’s effectiveness and and validate the initial prototype.

“This is a completely new diagnostic platform. We think this is going to be valuable in very broad applications for clinical diagnostics, not just COVID-19,” said University of Rochester Medical Center researcher Benjamin Miller who is leading the project. “But one of the attractive aspects of this is there’s a pathway for this technology to eventually be used in a doctor’s office or a pharmacy. Our goal is to have a validated benchtop prototype by this winter, early spring at the latest.”

“It is exciting to see the sensors work developed by AIM Photonics, over the past five years, now play a part in more effective testing for COVID-19 and future diseases,” added Michael Cumbo, CEO of AIM Photonics. “The industry, academic, and government partnership is a fundamental piece of this institute. Together, we foster successful technology developments such as this optical chip, which in turn enables a very innovative diagnostic platform.”

Related Links:
University of Rochester Medical Center
AIM Photonics
Ortho Clinical Diagnostics



Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.